|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA |
CTD |
PMID:11872642 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
increases methylation |
ISO |
Beryllium results in increased methylation of ESR1 gene |
CTD |
PMID:11872642 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Hras |
Harvey rat sarcoma virus oncogene |
increases mutagenesis |
ISO |
Beryllium results in increased mutagenesis of HRAS gene |
CTD |
PMID:7545909 |
|
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
|
|
G |
Il1b |
interleukin 1 beta |
increases expression affects expression |
ISO |
Beryllium results in increased expression of IL1B mRNA Beryllium affects the expression of IL1B mRNA |
CTD |
PMID:8473757 PMID:8629860 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Tnf |
tumor necrosis factor |
increases expression increases secretion increases response to substance |
ISO |
Beryllium results in increased expression of TNF mRNA Beryllium results in increased secretion of TNF protein TNF promoter polymorphism results in increased susceptibility to Beryllium |
CTD |
PMID:8629860 PMID:12449171 PMID:15127972 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
decreases activity |
EXP |
beryllium trifluoride results in decreased activity of PDXP protein |
CTD |
PMID:24338473 |
|
NCBI chr15:78,796,342...78,803,717
Ensembl chr15:78,798,119...78,803,717
|
|
G |
Pgp |
phosphoglycolate phosphatase |
decreases activity |
EXP |
beryllium trifluoride results in decreased activity of PGP protein |
CTD |
PMID:24338473 |
|
NCBI chr17:24,689,400...24,692,084
Ensembl chr17:24,689,366...24,692,084
|
|